Screener
Kailera Therapeutics KLRA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Kailera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026.
- Filed
- May 26, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-239417
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $111,826 | $160,267 |
| Marketable securities | 407,348 | 385,789 |
| Prepaid expenses and other current assets | 11,141 | 11,481 |
| Total current assets | 530,315 | 557,537 |
| Property and equipment, net | 1,854 | 1,955 |
| Restricted cash | 761 | 761 |
Item 1. Financial Statements.
FAQ
- What is Kailera Therapeutics's short-term investments?
- Kailera Therapeutics (KLRA) reported short-term investments of $407.35M in Q1 2026.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Kailera Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude